Shamburg News · 8-K filed Oct 27, 2026, 8:55 AM EDT
Lifeward Appoints Ronen Tsimerman as Chief Financial Officer Effective November 1, 2026
LFWD · Lifeward Ltd.
- Leadership change
- Materiality: high
On October 26, 2026, the Board of Directors of Lifeward Ltd. appointed Ronen Tsimerman as Chief Financial Officer, principal financial officer and principal accounting officer, effective November 1, 2026. The Company and Mr. Tsimerman will enter into an employment agreement providing for a gross monthly base salary of NIS 70,000 and a target annual bonus of not less than four monthly salaries, subject to shareholder approval of the renewed compensation policy at the October 30, 2026 annual general meeting. Mr. Tsimerman most recently served as chief financial officer of Scopio Labs Ltd. and previously as CFO of IceCure Medical Ltd.
Source: SEC EDGAR, Form 8-K, Item 5.02, accession 0001178913-26-004856.
Written from the filing by Shamburg Markets. Figures are as reported by the company.